|
DEPDC1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.617900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.232800E-01 |
| Normal-vs-Stage2 |
4.049900E-02 |
| Normal-vs-Stage3 |
3.531600E-01 |
| Normal-vs-Stage4 |
7.266000E-01 |
| Stage1-vs-Stage2 |
5.614400E-01 |
| Stage1-vs-Stage3 |
6.781800E-01 |
| Stage1-vs-Stage4 |
5.301000E-01 |
| Stage2-vs-Stage3 |
1.797360E-01 |
| Stage2-vs-Stage4 |
2.039800E-01 |
| Stage3-vs-Stage4 |
7.400000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.415100E-04 |
| Normal-vs-AfricanAmerican |
6.870600E-01 |
| Normal-vs-Asian |
5.919600E-01 |
| Caucasian-vs-AfricanAmerican |
2.494000E-01 |
| Caucasian-vs-Asian |
2.161000E-01 |
| AfricanAmerican-vs-Asian |
8.864600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.933800E-02 |
| Normal-vs-Female |
9.349800E-01 |
| Male-vs-Female |
1.876790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.185500E-04 |
| Normal-vs-Extreme_Weight |
7.78069999540776E-08 |
| Normal-vs-Obese |
4.301200E-01 |
| Normal-vs-Extreme_Obese |
4.495600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.751900E-02 |
| Normal_Weight-vs-Obese |
2.818000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.712400E-01 |
| Extreme_Weight-vs-Obese |
6.376500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.441600E-01 |
| Obese-vs-Extreme_Obese |
4.157800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.891400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.003630E-01 |
| Normal-vs-Age(61-80Yrs) |
2.481400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.6536999991601E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.048000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.945170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.454410E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.506200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.715400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.267850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.54159999999593E-05 |
| Normal-VS-Type2 PRCC |
7.863600E-02 |
| Normal-VS-KIRP CIMP |
4.496000E-02 |
| Normal-VS-Unclassified PRCC |
1.4172000000201E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.016000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.67100000000909E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.836800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.735000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.224840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.996600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.155500E-04 |
| Normal-vs-N1 |
1.502230E-01 |
| Normal-vs-N2 |
6.073000E-01 |
| N0-vs-N1 |
9.969900E-04 |
| N0-vs-N2 |
3.134400E-01 |
| N1-vs-N2 |
3.634000E-01 |
|
|
